Please wait
Healthcare · Healthcare Plans · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$46.3B
90.0%
36.51
Current price
$383.23
-0.6% todayUpdated 20 min ago
Open
$392.71
Previous close
$385.54
Day range
$382.11 – $397.33
Volume
N/A
36.5x P/E
Awaiting filing
90.0% yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for HUM, with its range and direction at a glance.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Investors usually follow HUM for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 69/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$694M
TTM (2026-06-30)
ROE
6.9%
Return on equity
ROA
3.9%
Return on assets
Debt / equity
0.74
Lower is usually safer.
P/B ratio
2.41
Useful for book value support.
Dividend yield
90.0%
Current income signal.
85/100
Direction
Range-bound
Main supports
Recent price behavior and momentum still support follow-through.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
$402.07
Analyst view
Buy
Analyst target
$418.61
Forecast refresh
Updated just now
Quality score
67
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
$0.89
2024-12-31
Payment: TBA | Qualification: 2024-12-31 | Yield at declaration: N/A
$0.89
2024-09-30
Payment: TBA | Qualification: 2024-09-30 | Yield at declaration: N/A
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+5.3% across the latest saved price window.
Volatility
Low
Beta is 0.74. Price has historically moved more calmly than the wider market.
52-week position
83% of range
Price is trading close to its 52-week high.
Volume confirmation
N/A
Comparable volume data is not available.
policy_stability_and_support
HUM may also move because the HEALTHCARE sector may benefit from policy_stability_and_support. Confidence 60%.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
HUM
Humana Inc.
Price: $383.23
P/E: 36.509468
Yield: 90.0%
ABBV
AbbVie Inc.
Price: $256.42
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.36
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $159.79
P/E: 27.310226
Yield: 0.0%
Industry
Healthcare Plans
Employees
67060
Exchange
NYQ
Ticker
HUM
